Formulation development of intermediate release Nimesulide tablets by CCRD for IVIVC studies

Journal Title: Pakistan Journal of Pharmaceutical Sciences - Year 2014, Vol 27, Issue 4

Abstract

 Simple and cost effective study consisting of three steps, comparison of micromeritic properties of different blends i.e. placebo without API and Nimesulide containing, Use of central composite design (CCRD) for intermediate release Nimesulide tablets and stability results of three selected Nimesulide tablet formulations which were calculated by using R Gui. Different concentrations of Avicel, hydroxypropyl methyl cellulose (HPMC) and magnesium stearate were used as variables in central composite design and two types blend i.e., with or without Nimesulide were selected for bulk density, tap density, percentage compressibility; angle of repose and Hausner’s ratio. Blending rate constant was performed after applying the different mixing times like 3, 6, 9 and 12 minutes. Twenty intermediate release formulations were designed and three formulations were chosen for compression by direct compression method on the basis of compressibility index. Physicochemical properties and best release pattern in four hours in different dissolution medium were successfully measured. Relative densities, porosity of tablets were compared with tensile strength of tablet and weight variation, hardness, friability and dissolution was performed by simple experiments. Presence of Nimesulide in the bulk increased all micromeratic tests while 9 minutes was best mixing time. The hardness of NM containing tablets increased with the increase of relative density. The release pattern was further analyzed by model dependent i.e. zero order, first order and Higuchi, Korse-meyer and Pappas, Hixson Crowell and model independent kinetic model i.e., f2 value respectively. R Gui explained the F16 formulation shows the best result in stability studies with shelf life 72 months.

Authors and Affiliations

Muhammad Hanif , Muhammad Harris Shoaib , Rabia Ismail Yousuf , Shahnila Sattar , Muhammad Nadeem , Liaqat Hussain , Muhammad Usman Zia , Iyad Naeem Muhammad , Muhammad Uzair , Imran Qadir

Keywords

Related Articles

 Inhibitory effect of Aristolochia fruit on Cytochrome P450 isozymes in vitro and in vivo

 The mature fruits of Aristolochia debilis, known in China by the name, “Madouling” has been popularly prescribed in Asia, particularly in China, to treat a range of conditions including gynaecological problems, art...

 Oritavancin – A new semisynthetic lipoglycopeptide agent to tackle the challenge of resistant gram positive pathogens

 Natural glycopeptide antibiotics like vancomycin and teicoplanin have played a significant role in countering the threat posed by Gram-positive bacterial infections. The emergence of resistance to glycopeptides amo...

 Synthesis and biological evaluation of some novel furan derivatives

 The present work involved cyclization of Schiff bases to azetidine-2-one and thiazolidine 4-one derivatives. The schiff bases (IIIa-j) were obtained upon reaction between electrophillic carbon atom of furfuraldehyd...

 Effect of renin inhibition on adipokines in diabetic rats

 Insulin resistance predicts development of type 2 diabetes mellitus (DM). Adipocytes release tumor Necrosis factor-alpha (TNF-α), and adiponectin. They modulate whole-body insulin sensitivity . The disturbance in t...

 Coumarins and flavonoid from Murraya paniculata (L.) Jack: Antibacterial and anti-inflammation activity

 The ethyl acetate extract of leaves of Murraya paniculata (L.) Jack was described in the previous in vitro study on the inhibition effect on the growth of periodontopathic bacteria and the reduction of cytokines fr...

Download PDF file
  • EP ID EP94315
  • DOI -
  • Views 106
  • Downloads 0

How To Cite

Muhammad Hanif, Muhammad Harris Shoaib, Rabia Ismail Yousuf, Shahnila Sattar, Muhammad Nadeem, Liaqat Hussain, Muhammad Usman Zia, Iyad Naeem Muhammad, Muhammad Uzair, Imran Qadir (2014).  Formulation development of intermediate release Nimesulide tablets by CCRD for IVIVC studies. Pakistan Journal of Pharmaceutical Sciences, 27(4), 785-792. https://europub.co.uk./articles/-A-94315